Tick-borne encephalitis vaccines: past and present (Q36284566)

13 August 2017

1 reference

title

Tick-borne encephalitis vaccines: past and present (English)

1 reference

13 August 2017

tick-borne encephalitis

1 reference

Olaf Zent

1

1 reference

PubMed ID

16221075

13 August 2017

Michael Bröker

series ordinal

2

1 reference

13 August 2017

1 October 2005

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

4

1 reference

13 August 2017

5

1 reference

13 August 2017

747-755

1 reference

Epidemiology and ecology of TBE relevant to the production of effective vaccines

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

21 January 2018

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Addressing parents' concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

21 January 2018

MMR vaccine and allergy

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Risk of Anaphylaxis After Vaccination of Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

A new accelerated vaccination schedule for rapid protection against hepatitis A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Tick-borne encephalitis in childhood--consensus 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Tickborne meningoencephalitis, first case after 19 years in northeastern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Risk and prevention of tick-borne encephalitis in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Novel flavivirus or new lineage of West Nile virus, central Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Louping ill in man: a forgotten disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

Complement receptor mediates enhanced flavivirus replication in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.747

21 January 2018

Identifiers

DOI

10.1586/14760584.4.5.747

1 reference

13 August 2017

1 reference

PubMed ID

16221075